Bill > S2103

This bill aims to enhance substance use prevention, treatment, and education by implementing several key provisions. It mandates training for law enforcement officers on responding to drug-related overdoses and applying specific laws related to controlled substances. The bill also requires the creation and distribution of a list of non-opioid pain management alternatives approved by the FDA, aiming to reduce reliance on opioids. Furthermore, it introduces requirements for hospitals to report on infants exposed to controlled substances and hospitalizations due to drug ingestion, and mandates that driver education courses include modules on addiction. The bill also establishes protocols for verbal substance use disorder screenings in schools, ensuring confidentiality and reporting of results. It introduces new regulations for prescribers, including mandatory training on pain management and addiction risks, and requires informed consent from parents or guardians before prescribing opioids to minors. A significant provision is the establishment of a Drug Stewardship Program, requiring manufacturers to manage the collection and disposal of unwanted drugs, and a Prescription Drug Awareness Program funded by manufacturer assessments to support public and professional education on prescription drug abuse. The bill also strengthens mental health and substance use disorder parity in insurance coverage, requiring insurers to provide adequate access to pain management alternatives and imposing penalties for violations. Finally, it establishes rehabilitation programs for pharmacists dealing with substance use issues and bans the sale of powdered alcohol.